Skip to main content
Fig. 6 | BMC Cardiovascular Disorders

Fig. 6

From: Sacubitril/valsartan inhibits the proliferation of vascular smooth muscle cells through notch signaling and ERK1/2 pathway

Fig. 6

The expression of p-ERK1/2 in VSMCs.. 1: Control group, 2: AngII (10− 6mol/L) group, 3: AngII (10− 6mol/L) + Entresto (10− 5mol/L) group. (5A) The expression of p-ERK1/2 at the protein level was detected by Western Blot after Entresto acted for 1 h before Ang II stimulation for 24 h. (5B) This is the quantization diagram, mean ± SEM (n = 3), a: p < 0.05, compared with the control group, b: p < 0.05, compared with Ang II group

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us